Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Jun-15 | Jun-16 | Jun-17 | Jun-18 | Jun-19 | Jun-20 | Jun-21 | Jun-22 | Jun-23 | Jun-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 99 | 85 | 70 | 66 | 55 | 61 | 84 | 61 | 56 | 63 | | 68 |
% Growth | NA | -15.0% | -17.4% | -5.5% | -16.9% | 11.3% | 38.1% | -27.4% | -8.3% | 11.6% | | |
| | | | | | | | | | | | |
Cost of Revenue | (71) | (62) | (50) | (48) | (39) | (44) | (56) | (42) | (42) | (44) | | (48) |
Gross Profit | 28 | 23 | 20 | 19 | 16 | 17 | 28 | 19 | 14 | 19 | | 21 |
% Revenue | 28.6% | 27.2% | 28.0% | 28.0% | 29.1% | 28.0% | 33.2% | 31.8% | 24.8% | 30.3% | | 30.0% |
| | | | | | | | | | | | |
Research and Development | (20) | (15) | (12) | (13) | (13) | (13) | (15) | (15) | (14) | (10) | | (10) |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (36) | (37) | (30) | (31) | (27) | (23) | (24) | (23) | (21) | (21) | | (22) |
Other Inc / (Exp) | (7) | 39 | (0) | 64 | 17 | 1 | 3 | 8 | 3 | 0 | | (2) |
Total Operating Exp | (63) | (13) | (43) | 21 | (23) | (36) | (36) | (30) | (32) | (31) | | (34) |
| | | | | | | | | | | | |
Operating Income | (35) | 10 | (23) | 39 | (7) | (19) | (7) | (10) | (18) | (12) | | (13) |
% Revenue | -34.8% | 12.2% | -33.3% | 59.1% | -13.1% | -30.3% | -8.8% | -16.7% | -31.9% | -18.6% | | -19.5% |
| | | | | | | | | | | | |
Interest Expense | 0 | 0 | 0 | 1 | 2 | 1 | (0) | 0 | 1 | 1 | | 1 |
Pre-tax Income | (34) | 11 | (23) | 40 | (5) | (18) | (8) | (10) | (17) | (11) | | (13) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 1 | (8) | (0) | (0) | 2 | 0 | (0) | (1) | (0) | (0) | | (0) |
Net Income to Company | (33) | 3 | (23) | 40 | (4) | (18) | (8) | (11) | (17) | (11) | | (13) |
% Margin | -33.6% | 3.2% | -32.7% | 61.2% | -7.0% | -28.7% | -9.0% | -17.9% | -29.7% | -17.2% | | -18.8% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (0) | (0) | (0) | 0 | (0) | (0) | (0) | 0 | (0) | (0) | | 0 |
Net Income to Stockholders | (33) | 3 | (23) | 40 | (4) | (18) | (8) | (11) | (17) | (11) | | (13) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | (33) | 3 | (23) | 40 | (4) | (18) | (8) | (11) | (17) | (11) | | (13) |
% Margin | -33.6% | 3.1% | -32.8% | 61.2% | -7.0% | -28.7% | -9.1% | -17.9% | -29.7% | -17.2% | | -18.8% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | (0.47) | 0.04 | (0.33) | 0.57 | (0.05) | (0.25) | (0.11) | (0.16) | (0.24) | (0.15) | | (0.18) |
Diluted EPS (Continuing Ops) | (0.47) | 0.04 | (0.33) | 0.57 | (0.05) | (0.25) | (0.11) | (0.16) | (0.24) | (0.15) | | (0.18) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 70.33 | 70.33 | 70.33 | 70.33 | 70.40 | 70.40 | 70.40 | 70.40 | 70.40 | 70.40 | | 69.96 |
WA Diluted Shares Out. | 70.33 | 70.56 | 70.33 | 70.54 | 70.40 | 70.40 | 70.40 | 70.40 | 70.40 | 70.40 | | 69.96 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (34) | 11 | (23) | 40 | (5) | (18) | (8) | (10) | (17) | (11) | | (13) |
Addback: Net Interest Expense | (0) | (0) | (0) | (1) | (2) | (1) | 0 | (0) | (1) | (1) | | (1) |
Addback: Other Non Operating Expenses, Total | 12 | (4) | 1 | (0) | 0 | 0 | (1) | 2 | (1) | (0) | | 1 |
Addback: Depreciation & Amortization | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 1 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | (4) | (2) | (1) | 0 | 0 | 1 | (0) | 0 | 0 | (0) | | (0) |
Addback: Gain (Loss) On Sale Of Assets | (0) | 0 | (0) | (0) | 0 | 0 | 0 | (10) | (3) | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | (34) | 0 | (64) | (18) | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | (2) | (2) | (1) | 0 | 0 | | 0 |
Adjusted EBITDA | (27) | (29) | (23) | (25) | (24) | (19) | (10) | (18) | (21) | (12) | | (11) |
% Margin | -26.8% | -33.8% | -32.5% | -37.6% | -44.1% | -30.8% | -12.2% | -29.7% | -37.5% | -18.9% | | -16.6% |
| | | | | | | | | | | | |
Adjusted EBIT | (27) | (29) | (23) | (25) | (24) | (19) | (11) | (18) | (21) | (12) | | (11) |
% Margin | -27.5% | -34.4% | -32.8% | -37.9% | -44.3% | -31.2% | -12.5% | -30.1% | -37.7% | -19.0% | | -16.7% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | (33) | 3 | (23) | 40 | (4) | (18) | (8) | (11) | (17) | (11) | | (13) |
Addback: Unusual Items | (5) | (35) | (1) | (64) | (17) | (1) | (2) | (10) | (3) | (0) | | 1 |
Less: Tax Benefit of Unusual Items (26%) | 1 | 9 | 0 | 17 | 5 | 0 | 1 | 3 | 1 | 0 | | (0) |
Adjusted Net Income | (37) | (23) | (23) | (7) | (17) | (18) | (9) | (18) | (19) | (11) | | (12) |
% Margin | -37.2% | -27.7% | -33.4% | -10.3% | -30.5% | -29.6% | -10.9% | -30.1% | -33.2% | -17.3% | | -17.9% |